Madison Muller

Patients given the drug, called sigvotatug vedotin, didn't live significantly longer than those given standard therapy with docetaxel, Pfizer said in a statement. Pfizer got the drug in its $43 billion purchase of Seagen Inc. in late 2023. The company had expected it could be the first of a new class of drugs that deliver potent cancer-killing compounds directly to tumors, called directed antibody-drug conjugates.

The U.S. Department of Health and Human Services wants to remove some of the stigma from testosterone treatment. The agency, through the U.S. Food and Drug Administration, is asking manufacturers to t

Novo Nordisk A/S said its market research shows twice as many US Medicare recipients would rather take a weight-loss pill over a shot, a preference the Danish drugmaker will try to use to grab market share from its rival Eli Lilly & Co.

As the field of mayoral contenders continues to expand, a new poll released today explains why: Incumbent Brandon Johnson is in weak political shape.

El auge de los medicamentos del mercado negro y la posibilidad de su legalización han desatado una carrera entre emprendedores, inversionistas y empresas de salud para capitalizar este nuevo mercado.

The long-awaited benefit could reshape obesity care for older Americans, though logistics could take some time to iron out

Compass Pathways Plc shares fell almost 10% Tuesday after a pivotal study of its experimental psilocybin-based therapy reinforced the drug’s durability for treatment-resistant depression but appeared to leave investors underwhelmed by the efficacy details.

Eli Lilly & Co. agreed to buy AtaiBeckley Inc. for as much as $3.8 billion, underscoring growing interest from large drugmakers in the once-fringe area of psychedelic medicine.

Kalshi Inc. is expanding in biotechnology by offering wagers on the outcomes of clinical trials and regulatory decisions, giving traders a more direct way to bet on key industry catalysts.

Bloomberg reported Wednesday that Kalshi is evaluating whether to offer wagers on flight-cancellation rates at specific airports.